injectable filler

In recent years, facelifts have been declining in popularity. This is partly due to the dramatic increase in nonsurgical options for facial rejuvenation. But how do nonsurgical options really compare to a facelift?

Preliminary study suggests it reduces ‘crow’s feet,’ but more research is needed. Preliminary industry-funded research suggests that a gel based on the active ingredient of the injectable Botox wrinkle treatment could help reduce the lines around the eyes known as crow’s feet — without the pain of needles

California-based pharmaceutical firm Allergan is on the second clinical stage of testing an eyelash lengthener as possible therapy for baldness.   Allergan Chief Executive Office David Pyott said the company expects to see data by the middle of 2012. The medication, Latisse, was approved by the U.S

California-based pharmaceutical firm Allergan is on the second clinical stage of testing an eyelash lengthener as possible therapy for baldness.   Allergan Chief Executive Office David Pyott said the company expects to see data by the middle of 2012. The medication, Latisse, was approved by the U.S.

U.S. drug regulators approved Allergan’s Botox for treating a specific kind of overactive bladder on Wednesday, setting the stage for wider use of the popular wrinkle treatment in those with bladder problems. The U.S.

As the Executive-Director of the IAPAM (International Association for Physicians in Aesthetic Medicine) I receive many calls and emails from physicians looking at entering the aesthetic medicine industry.  The most common request is for Botox training, many believe by only offering Botox, they will be on their way to vast riches.  The reality is that you certainly need to offer Botox treatments (it has been the number one non/minimally invasive cosmetic procedure for years), but it is highly commoditized. Which means, you don’t make much money!  If you are going to add aesthetics to your practice, it should be for the money.  For a typical Botox treatment, the patient may require 40 units of Botox.  By the time you incorporate the cost of the product & consumables (needles, gloves, saline, gauze, ice pack, office time) you have a cost of $240, but the going rate for Botox is $9/unit, so you’ve made $120. Typically a patient comes back every 4-6 months, so you’ll make $240-$360/yr from one Botox patient.  Now lets take a chemical peel treatment.  Your cost is $20 (product cost & consumables), but you charge $120, your profit is still $100, but you see this patient once a month instead of 3 times a year.

When it enters the U.S. market, Xeomin is expected to have a unit-to-unit equivalence to Botox, the standard aesthetic toxin in dermatology practices for years

A new medical trial in Australia is set to test whether Botox can be used to help people with asthma breathe more easily.

According to the American Society for Aesthetic Plastic Surgery, more than 2.4 million people last year got Botox, the world’s most popular “wrinkle eraser.”An average treatment costs nearly $400. With prices like that, many have been lining up to provide the treatment while youth-seeking patients search out bargains.